An observational study in Viral Pneumonia, sponsored by Central Hospital, Nancy, France. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2025-02-18.
Sponsored by Central Hospital, Nancy, France · Observational
The hypothesis was that a retrospective investigation of the molecular virological tests in a University hospital could be informative, with the aim to identify non-COVID-19 respiratory viruses during the circulation of SARS-CoV-2, according to systematic population data for public health knowledge.
The hypothesis was that a retrospective investigation of the molecular virological tests in a University hospital could be informative, with the aim to identify non-COVID-19 respiratory viruses during the circulation of SARS-CoV-2, according to systematic population data for public health knowledge:
146 studies on the registry are indexed under Pneumonia, Viral; 11 are open to participants now.
This study's enrollment of 18 is below the median of 210 across 54 observational studies indexed under Pneumonia, Viral.
Browse Pneumonia, Viral studies →Central Hospital, Nancy, France is the lead sponsor of 797 studies on the registry; 188 are open to participants now.
Counted across the registry records on this site, refreshed daily.
18 Intensive Care Unit (ICU)-patients, from the whole population of patients who were hospitalized for respiratory infections from early 2021 to mid-2022 in Nancy University hospital, France:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
18 ICU (Intensive Care Unit)-patients group, from the whole population of patients (1,614) who were hospitalized for respiratory infections from early 2021 to mid-2022 in Nancy University hospital, France.
Other: other: Observational
For 18 ICU patients, retrospective collection of routine bioclinical database (ICCA db)
Occurrence of positive viral PCR assays (not COVID-19) from hospitalizations for respiratory infections.
Number of patients with positive virological molecular tests (multiplex respiratory panels) from the beginning of 2021 to mid-2022, with the nature of the viruses detected and the chronology of occurrence of positive tests.
Time frame: 18 months, retrospectively
Real-life features of patients in Intensive care (from the whole population - Outcome 1) with positive viral PCR during infectious pneumonia.
For the group of patients in Intensive Care: * (i) number of positive molecular virological tests detecting respiratory viruses by FilmArray Pneumonia test * (ii) associated bioclinical data * (iii) medical impact of virological results in real life - progression of the infection and duration of thehospitalization.
Time frame: 18 months, retrospectively
Ran from Apr 2024 to primary completion in May 2024, 1 month.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France →